Inventor · disambiguated record
Charalambos Kaittanis
Also filed as: KAITTANIS CHARALAMBOS
17 granted patents·23 pending applications·61 citations·filing 2008–2024
91Inventor score
Files withALNYLAM PHARMACEUTICALS INC17MEMORIAL SLOAN KETTERING CANCER CENTER9UNIV CENTRAL FLORIDA RES FOUND INC5PEREZ JESUS MANUEL4PEREZ J MANUEL2
Top patents by PatentIndex Score
40 records- 0194US11149276B2Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Oct 19, 2021·4 cites·30 claims
- 0293US8883519B1Oxidase activity of polymeric coated cerium oxide nanoparticlesPEREZ J MANUEL·Filed 2010·Granted Nov 11, 2014·27 cites·38 claims
- 0391US8795731B1Cerium oxide nanoparticle-based device for the detection of reactive oxygen species and monitoring of chronic inflammationPEREZ JESUS MANUEL·Filed 2010·Granted Aug 5, 2014·13 cites·24 claims
- 0489US8795733B1Cerium-oxide nanoparticle based device for the detection of reactive oxygen species and monitoring of chronic inflammationPEREZ JESUS MANUEL·Filed 2012·Granted Aug 5, 2014·9 cites·20 claims
- 0584US11162103B2Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Nov 2, 2021·1 cites·23 claims
- 0684US9119391B1Polymer coated ceria nanoparticles for selective cytoprotectionPEREZ JESUS MANUEL·Filed 2008·Granted Sep 1, 2015·4 cites·12 claims
- 0782US12258565B2Complement component C3 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2024·Granted Mar 25, 2025·0 cites·28 claims
- 0881US10973925B2Methods and compositions for theranostic nanoparticlesUNIV CENTRAL FLORIDA RES FOUND INC·Filed 2016·Granted Apr 13, 2021·2 cites·9 claims
- 0974US12365896B2Complement component C3 iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Jul 22, 2025·0 cites·52 claims
- 1073US11649459B2Superoxide dismutase 1 (SOD1) iRNA compositions and methods of use thereof for treating or preventing superoxide dismutase 1-(SOD1-) associated neurodegenerative diseasesALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted May 16, 2023·0 cites·30 claims
- 1172US2024150767A1SUPEROXIDE DISMUTASE 1 (SOD1) iRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING SUPEROXIDE DISMUTASE 1- (SOD1-) ASSOCIATED NEURODEGENERATIVE DISEASESALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1270US11307199B2Oxidase activity of polymeric coated cerium oxide nano-particlesUNIV CENTRAL FLORIDA RES FOUND INC·Filed 2019·Granted Apr 19, 2022·0 cites·3 claims
- 1369US9109249B2Microbe detection via hybridizing magnetic relaxation nanosensorsNASER SALEH·Filed 2012·Granted Aug 18, 2015·1 cites·18 claims
- 1469US2022218827A1Delivery of therapeutic compounds with iron oxide nanoparticlesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 1566US12480125B2Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Nov 25, 2025·0 cites·20 claims
- 1666US9057094B1Nanoparticle-mediated methods for antimicrobial susceptibility testing of bacteriaPEREZ J MANUEL·Filed 2008·Granted Jun 16, 2015·0 cites·13 claims
- 1766US2019388542A1Delivery of therapeutic compounds with iron oxide nanoparticlesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Application pending·0 cites
- 1865US12097264B2Methods and compositions for theranostic nanoparticlesUNIV CENTRAL FLORIDA RES FOUND INC·Filed 2021·Granted Sep 24, 2024·0 cites·9 claims
- 1965US2024132895A1GLYCOGEN SYNTHASE KINASE 3 ALPHA (GSK3 ALPHA) iRNA COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2065US2023054210A1Compositions and methods for nanoparticle-based drug delivery and imagingMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 2165US2015231269A1Delivery of therapeutic compounds with iron oxide nanoparticlesSLOAN KETTERING INST CANCER·Filed 2013·Application pending·0 cites
- 2264US10261074B1Oxidase activity of polymeric coated cerium oxide nano-particlesUNIV CENTRAL FLORIDA RES FOUND INC·Filed 2014·Granted Apr 16, 2019·0 cites·6 claims
- 2363US2024018515A1Complement factor b (cfb) irna compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2462US2020222452A1Methods and compositions for cancer treatmentMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 2561US2019255101A1Differential tumor cell cytotoxicity via contact with coated cerium oxide nanoparticlesUNIV CENTRAL FLORIDA RES FOUND INC·Filed 2019·Application pending·0 cites
- 2658US10213458B2Differential tumor cell cytotoxicity via contact with coated cerium oxide nanoparticlesPEREZ JESUS MANUEL·Filed 2015·Granted Feb 26, 2019·0 cites·2 claims
- 2757US2024011032A1Snca irna compositions and methods of use thereof for treating or preventing snca-associated neurodegenerative diseasesALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2857US2023159933A1Compositions and methods for silencing scn9a expressionALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2956US2020315981A1Compositions and methods for nanoparticle-based drug delivery and imagingMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 3055US2025283071A1Modified double stranded oligonucleotidesALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3155US2024294906A1Atxn2 irna compositions and methods of use thereof for treating or preventing atxn2-associated neurodegenerative diseasesALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3255US2024175028A1DOSING OF siRNA COMPOUNDS TO THE CISTERNA MAGNAALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3355US2023136787A1Compositions and methods for silencing vegf-a expressionALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3453US2018021265A1Compositions and methods for nanoparticle-based drug delivery and imagingMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Application pending·0 cites
- 3552US2023203486A1MICROTUBULE ASSOCIATED PROTEIN TAU (MAPT) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3652US2020054744A1Psma-related therapiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 3750US2023126233A1LEUCINE-RICH REPEAT KINASE 2 (LRRK2) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3848US2015087605A1Compositions and Methods Comprising Carboxylic Acid-Containing Small MoleculesUNIV CENTRAL FLORIDA RES FOUND·Filed 2014·Application pending·0 cites
- 3943US2018296595A1Methods and compositions for cancer treatmentMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Application pending·0 cites
- 4042US2017252433A1Psma-related therapiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Charalambos Kaittanis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →